iifl-logo

Wockhardt Ltd Annually Results

1,831.1
(18.40%)
Jun 11, 2025|12:00:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Financials

Particulars (Rupees in Crores.)Mar-2025Mar-2024Mar-2023Mar-2022Mar-2021

Gross Sales

3,012

2,798

2,651

3,230

2,708

Excise Duty

0

0

0

0

0

Net Sales

3,012

2,798

2,651

3,230

2,708

Other Operating Income

0

0

0

0

0

Other Income

62

83

122

20

1,476

Total Income

3,074

2,881

2,773

3,250

4,184

Total Expenditure

2,619

2,773

2,844

3,115

2,773

PBIDT

455

108

-71

135

1,411

Interest

254

305

302

299

249

PBDT

201

-197

-373

-164

1,162

Depreciation

217

223

251

247

246

Minority Interest Before NP

0

0

0

0

0

Tax

7

16

12

38

192

Deferred Tax

34

36

-15

-170

36

Reported Profit After Tax

-57

-472

-621

-279

688

Minority Interest After NP

-10

-9

-62

-35

2

Net Profit after Minority Interest

-47

-463

-559

-244

686

Extra-ordinary Items

0

-57.83

-288.35

-166.08

0

Adjusted Profit After Extra-ordinary item

-47

-405.17

-270.65

-77.92

686

EPS (Unit Curr.)

-3.02

-32.05

-38.79

-20.24

61.95

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

81

77

72

72

55.39

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

15.1

3.85

-2.67

4.17

52.1

PBDTM(%)

6.67

-7.04

-14.07

-5.07

42.9

PATM(%)

-1.89

-16.86

-23.42

-8.63

25.4

Wockhardt: Related NEWS

Wockhardt’s antibiotic gets Fast Track designation from USFDA
7 Oct 2024|01:54 PM

WCK 6777 is the only once-a-day antibiotic in the global pipeline designated for outpatient parenteral antimicrobial therapy (OPAT).

Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.